Downloads
Title
Source name
Date

FDA Roundup: October 11, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA orangebook
12 Oct 2024

Temporary Policies for Compounding Certain Parenteral Drug Products

Temporary Policies for Compounding Certain Parenteral Drug Products

FDA orangebook
12 Oct 2024

FDA Clinical Investigator Training Course (CITC) 2024 - 12/10/2024

FDA Clinical Investigator Training Course (CITC) 2024

FDA orangebook
12 Oct 2024

Good Clinical Practice

The following resources are provided to help investigators, sponsors, and contract research organizations who conduct clinical studies on investigational new drugs comply with U.S. law and regulations covering good clinical practice (GCP).

FDA orangebook
12 Oct 2024

Drug Trials Snapshots: XDEMVY

XDEMVY is an ectoparasiticide that treats Demodex blepharitis. Blepharitis is a type of eyelid infection.

FDA orangebook
12 Oct 2024

FDA Approves New Treatment for Hemophilia A or B

The FDA approved a new treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 12 years of age and older with hemophilia A or B, both without inhibitors.

FDA orangebook
12 Oct 2024

Infusion Pump Recall: Zyno Medical Removes Z-800, Z-800F, Z-800W, and Z800WF Infusion Pumps due to an Air-in-Line Software Defect That May Allow Larger than Expected Air Bubbles to Enter Patients

Zyno Medical Z-800 infusion pumps allow for infusions through the blood vessels but a software defect may allow air bubbles to enter the patient.

FDA orangebook
11 Oct 2024

October 11, 2024

The FDA approved a new treatment for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 12 years of age and older with hemophilia A or B, both without inhibitors.

FDA orangebook
11 Oct 2024

Empower Pharmacy. Houston, TX. 483 issued 8/28/2024

Task Description Request Please post to the OII FOIA Electronic Reading Room Record Date 8/28/2024 Short Title (70 char) Empower Pharmacy. Houston, TX. 483 issued 8/28/2024 FEI Number 3011887629 Firm

FDA orangebook
11 Oct 2024

Barclay, Luke, and Pillai Specialty Pharmacy PLLC, dba Meta Pharmacy Services. Las Vegas, NV. WLCO issued 3/15/2024

Task Description Request Please post to the OII FOIA Electronic Reading Room Record Date 3/15/2024 Short Title (70 char) Barclay, Luke, and Pillai Specialty Pharmacy PLLC. Las Vegas, NV. WLCO issued 3

FDA orangebook
11 Oct 2024

Drug Trials Snapshots: TZIELD

TZIELD is a drug that is used to delay the onset of type 1 diabetes in children and adults who are at high risk for type 1 diabetes.

FDA orangebook
11 Oct 2024

FDA approves inavolisib with palbociclib and fulvestrant for endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative, advanced breast cancer

On October 10, 2024, the Food and Drug Administration approved inavolisib (Itovebi, Genentech, Inc.) with palbociclib and fulvestrant for adults with endocrine-resistant, PIK3CA-mutated, hormone recep

FDA orangebook
11 Oct 2024

La FDA advierte a los consumidores de que no compren ni utilicen productos Umary y Amazy, ya que pueden ser perjudiciales para su salud

La FDA advierte a los consumidores de que no compren ni utilicen productos Umary y Amazy, ya que pueden ser perjudiciales para su salud

FDA orangebook
10 Oct 2024

Bioterrorism and Drug Preparedness

FDA is working with other federal agencies to make sure adequate supplies of medicine and vaccines are available to the American public.

FDA orangebook
09 Oct 2024

Radiation Emergencies

Radiation Emergencies

FDA orangebook
09 Oct 2024

Federal Court Enters Consent Decree Against Rizo Lopez Foods Inc. Following Multistate Outbreak of Listeriosis Linked to Queso Fresco and Cotija Cheese Products

U.S. District Court for the Eastern District of California entered a consent decree of permanent injunction against Rizo Lopez Foods Inc. prohibiting the company from manufacturing and selling certain

FDA orangebook
09 Oct 2024

Hurricane Helene: Baxter's manufacturing recovery in North Carolina

Information and updates on CDER-regulated drug and biologic products

FDA orangebook
09 Oct 2024

Updates on 2024 Hurricane Season

CDER updates on recovery efforts during the 2024 Hurricane season, including information on Baxter's manufacturing recovery in North Carolina and updates to CDER-regulated products,

FDA orangebook
09 Oct 2024

October 8, 2024

U.S. District Court for the Eastern District of California entered a consent decree of permanent injunction against Rizo Lopez Foods Inc. prohibiting the company from manufacturing and selling certain

FDA orangebook
09 Oct 2024

Former Nurse Pleads Guilty in Connection with Diverting Fentanyl from ICU Patient

FDA-OCI, District of New Hampshire, Concord, Northfield, New Hampshire, Lisa Richardson, Concord Hospital

FDA orangebook
08 Oct 2024

Mexicanrxpharm.com - 693163 - 09/30/2024

Notice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the Internet

FDA orangebook
08 Oct 2024
FDA orangebook
08 Oct 2024

MMC Healthcare Ltd. - 684644 - 09/24/2024

CGMP/Finished Pharmaceuticals/Adulterated

FDA orangebook
08 Oct 2024

Nanchang Anobri Pharmaceutical Co., Ltd. - 11/21/2023

Nanchang Anobri Pharmaceutical Co., Ltd. - 11/21/2023. Country: China. Record Type: 483

FDA orangebook
08 Oct 2024

Aqualex Co., Ltd. - 10/20/2023

Aqualex Co., Ltd. - 10/20/2023. Country: Korea (Republic of). Record Type: 483

FDA orangebook
08 Oct 2024
We use cookies to enhance your browsing experience. By continuing to use our website you agree to our policies Read the policyAccept